BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12647431)

  • 1. [Mirtazapine--an antidepressant].
    Landowski J
    Psychiatr Pol; 2002; 36(6 Suppl):125-30. PubMed ID: 12647431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mirtazapine versus fluoxetine on "sleep quality".
    Lawrence RW
    J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeated episodes of neutropenia triggered by mirtazapine.
    Civalier KA; Krahn LE; Agrwal N
    Psychosomatics; 2009; 50(3):299-300. PubMed ID: 19567774
    [No Abstract]   [Full Text] [Related]  

  • 4. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerance assessment of mitrazapine in the treatment of depression in the elderly--preliminary report].
    Florkowski A; Gruszczyński W; Zboralski K
    Psychiatr Pol; 2002; 36(6 Suppl):143-6. PubMed ID: 12647433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z
    Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine, an antidepressant.
    Puzantian T
    Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Motivational therapy can fail here. Sleep disorders in depressions].
    MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526634
    [No Abstract]   [Full Text] [Related]  

  • 9. First report of mirtazapine-induced arthralgia.
    Jolliet P; Veyrac G; Bourin M
    Eur Psychiatry; 2001 Dec; 16(8):503-5. PubMed ID: 11777743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of efficacy and tolerability of mirtazapine treatment of patients with depression].
    Beszłej A; Grzesiak M
    Psychiatr Pol; 2002; 36(6 Suppl):115-23. PubMed ID: 12647430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety in overdose of mirtazapine: a case report.
    Gerritsen AW
    J Clin Psychiatry; 1997 Jun; 58(6):271. PubMed ID: 9228894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mirtazapine--the new standard].
    Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
    [No Abstract]   [Full Text] [Related]  

  • 14. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
    Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
    J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mirtazapine--pharmacologic action and clinical advantages].
    Rihmer Z; Purebl G
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):35-40. PubMed ID: 19731817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression.
    Borkowska A; Drozdz W; Ziółkowska-Kochan M; Rybakowski J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):131-6. PubMed ID: 18399031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
    Radhakishun FS; van den Bos J; van der Heijden BC; Roes KC; O'Hanlon JF
    J Clin Psychopharmacol; 2000 Oct; 20(5):531-7. PubMed ID: 11001237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of mirtazapine: revisited.
    Davis J; Barkin RL
    Am Fam Physician; 1999 Sep; 60(4):1101. PubMed ID: 10507741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.